KRAS and colorectal carcinoma: In this study, by combining the data from four studies with 6697 patients, we found that LCC patients with KRAS mutation has a poor prognosis, but RCC patients with KRAS mutation did not show the similar results, which can partly explain the inconsistent results of the prognostic value of KRAS status in CRC patients.